Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SHR-2004 for VTE prevention in ovarian cancer surgery
NCT06220123Phase 2Completed
- Sponsor
- Beijing Suncadia Pharmaceuticals Co., Ltd.
- Start
- Feb 2024
- Primary completion
- Dec 2024
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of SHR-2004 in venous thromboembolism (VTE), sponsored by Beijing Suncadia Pharmaceuticals Co., Ltd.. Started Feb 2024; status: completed.
02
Drugs
SHR-2004
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT06220123.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06220123.